Carboprost Trometamol

Specification：250ug (Formulation strength)

Composition：

Description：

Storage：

Indications：
1.Failure of expulsion of the fetus during the course of treatment by another method; 2. Premature rupture of membranes in intrauterine methods with loss of drug and insufficient or absent uterine activity; 3. Requirement of a repeat intrauterine instillation of drug for expulsion of the fetus; 4. Inadvertent or spontaneous rupture of membranes in the presence of a previable fetus and absence of adequate activity for expulsion

Pharmacopeia：

DMF：

GMP：

Origin：India

Batch Size：100g

Registration status：
FDA：27865    A
EU：√  
CDE: Y20200000103  I

Advantage：
The only approved API used in US listed generic drugs
Exclusive API, independent review in CDE